Non-proliferating plasma cells detected in the salivary glands and bone marrow of autoimmune NOD.B10.H2b mice, a model for primary Sjögren’s syndrome

References

• Jonsson, R., A. I. Bolstad, K. A. Brokstad, and J. G. Brun. 2007. Sjogren’s syndrome – a plethora of clinical and immunological phenotypes with a complex genetic background. Ann. NY Acad. Sci. 1108: 433–447
   PubMed Web of Science ®Google Scholar
• Jonsson, R., P. Vogelsang, R. Volchenkov, et al. 2011. The complexity of Sjogren’s syndrome: novel aspects on pathogenesis. Immunol. Lett. 141: 1–9
   PubMed Web of Science ®Google Scholar
• Kassan, S. S., and H. M. Moutsopoulos. 2004. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch. Intern. Med. 164: 1275–1284
   PubMed Web of Science ®Google Scholar
• Mavragani, C. P., and H. M. Moutsopoulos. 2014. Sjogren’s Syndrome. Annu. Rev. Pathol. 9: 273–285
   PubMed Web of Science ®Google Scholar
• Gao, J., S. Killedar, J. G. Cornelius, et al. 2006. Sjogren’s syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease. J. Autoimmun. 26: 90–103
   PubMed Web of Science ®Google Scholar
• Hoffman, R. W., M. A. Alspaugh, K. S. Waggie, et al. 1984. Sjogren’s syndrome in MRL/l and MRL/n mice. Arthritis. Rheum. 27: 157–165
   PubMed Web of Science ®Google Scholar
• Jonsson, M. V., N. Delaleu, and R. Jonsson. 2007. Animal models of Sjogren’s syndrome. Clin. Rev. Allergy Immunol. 32: 215–24
   PubMed Web of Science ®Google Scholar
• Kunkel, E. J., and E. C. Butcher. 2003. Plasma-cell homing. Nat. Rev. Immunol. 3: 822–829
   PubMed Web of Science ®Google Scholar
• Skarstein, K., M. Wahren, E. Zaura, et al. 1995. Characterization of T cell receptor repertoire and anti-Ro/SSA autoantibodies in relation to sialadenitis of NOD mice. Autoimmunity. 22: 9–16
   PubMed Web of Science ®Google Scholar
• Kessler H. S. 1968. A laboratory model for Sjogren’s syndrome. Am. J. Pathol. 52: 671–685
   PubMed Web of Science ®Google Scholar
• Robinson, C. P., S. Yamachika, D. I. Bounous, et al. 1998. A novel NOD-derived murine model of primary Sjogren’s syndrome. Arthritis. Rheum. 41: 150–156
   PubMed Web of Science ®Google Scholar
• Humphreys-Beher, M. G., Y. Hu, Y. Nakagawa, et al. 1994. Utilization of the non-obese diabetic (NOD) mouse as an animal model for the study of secondary Sjogren’s syndrome. Adv. Exp. Med. Biol. 350: 631–636
   PubMedGoogle Scholar
• Wicker, L. S., B. J. Miller, L. Z. Coker, et al. 1987. Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse. J. Exp. Med. 165: 1639–1654
   PubMed Web of Science ®Google Scholar
• Nguyen, C., J. Cornelius, E. Singson, et al. 2006. Role of complement and B lymphocytes in Sjogren’s syndrome-like autoimmune exocrinopathy of NOD.B10-H2b mice. Mol. Immunol. 43: 1332–1339
   PubMed Web of Science ®Google Scholar
• Jonsson, R., E. Nginamau, and K. A Szyszko. 2007. Brokstad. Role of B cells in Sjogren’s syndrome – from benign lymphoproliferation to overt malignancy. Front. Biosci. 12: 2159–2170
   PubMed Web of Science ®Google Scholar
• Pers, J. O., and P. Youinou. 2013. Are the B cells cast with the leading part in the Sjogren’s syndrome scenario? Oral Dis. 20: 529–537
   PubMed Web of Science ®Google Scholar
• Youinou, P., V. Devauchelle-Pensec, and J. O. Pers. 2010. Significance of B cells and B cell clonality in Sjogren’s syndrome. Arthritis. Rheum. 62: 2605–2610
   PubMed Web of Science ®Google Scholar
• Pollard, R. P., J. Pijpe, H. Bootsma, et al. 2011. Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren's syndrome: a retrospective clinical study. J. Rheumatol. 38: 2198–2208
   PubMed Web of Science ®Google Scholar
• Szyszko, E. A., J. G. Brun, K. Skarstein, et al. 2011. Phenotypic diversity of peripheral blood plasma cells in primary Sjogren’s syndrome. Scand. J. Immunol. 73: 18–28
   PubMed Web of Science ®Google Scholar
• Manz, R. A., M. Lohning, G. Cassese, et al. 1998. Survival of long-lived plasma cells is independent of antigen. Int. Immunol. 10: 1703–1711
   PubMed Web of Science ®Google Scholar
• Vallerskog, T., I. Gunnarsson, M. Widhe, et al. 2007. Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. Clin. Immunol. 122: 62–74
   PubMed Web of Science ®Google Scholar
• DiLillo, D. J., Y. Hamaguchi, Y. Ueda, et al. 2008. Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice. J. Immunol. 180: 361–371
   PubMed Web of Science ®Google Scholar
• Cassese, G., S. Arce, A. E. Hauser, et al. 2003. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J. Immunol. 171: 1684–1690
   PubMed Web of Science ®Google Scholar
• Szyszko, E. A., K. A. Brokstad, G. Oijordsbakken, et al. 2011. Salivary glands of primary Sjogren’s syndrome patients express factors vital for plasma cell survival. Arthritis. Res. Ther. 13: R2
   PubMed Web of Science ®Google Scholar
• Jonsson, M. V., P. Szodoray, S. Jellestad, et al. 2005. Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren’s syndrome. J. Clin. Immunol. 25: 189–201
   PubMed Web of Science ®Google Scholar
• Szyszko, E. A., K. Skarstein, R. Jonsson, and K. A. Brokstad. 2011. Distinct phenotypes of plasma cells in spleen and bone marrow of autoimmune NOD.B10.H2b mice. Autoimmunity 44: 415–426
   PubMed Web of Science ®Google Scholar
• Skarstein, K., A. H. Nerland, M. Eidsheim, et al. 1997. Lymphoid cell accumulation in salivary glands of autoimmune MRL mice can be due to impaired apoptosis. Scand. J. Immunol. 46: 373–378
   PubMed Web of Science ®Google Scholar
• Jonsson, R., A. Tarkowski, K. Backman, et al. 1987. Sialadenitis in the MRL-l mouse: morphological and immunohistochemical characterization of resident and infiltrating cells. Immunology 60: 611–616
   PubMed Web of Science ®Google Scholar
• Jonsson, M. V., N. Delaleu, K. A. Brokstad, et al. 2006. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland. Arthritis Rheum. 54: 2300–2305
   PubMed Web of Science ®Google Scholar
• Dorner, T., and A. Radbruch. 2007. Antibodies and B cell memory in viral immunity. Immunity 27: 384–392
   PubMed Web of Science ®Google Scholar
• Manz, R. A., A. E. Hauser, F. Hiepe, and A. Radbruch. 2005. Maintenance of serum antibody levels. Annu. Rev. Immunol. 23: 367–386
   PubMed Web of Science ®Google Scholar
• Tew, J. G., R. M. DiLosa, G. F. Burton, et al. 1992. Germinal centers and antibody production in bone marrow. Immunol. Rev. 126: 99–112
   PubMed Web of Science ®Google Scholar
• Jonsson, R., A. Tarkowski, and L. Klareskog. 1986. A demineralization procedure for immunohistopathological use. EDTA treatment preserves lymphoid cell surface antigens. J. Immunol. Methods. 88: 109–114
   PubMed Web of Science ®Google Scholar
• Winter, O., K. Moser, E. Mohr, et al. 2010. Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow. Blood. 116: 1867–1875
   PubMed Web of Science ®Google Scholar
• Nahar, N. N., S. E. Tague, J. Wang, et al. 2013. Histological characterization of bone marrow in ectopic bone, induced by devitalized Saos-2 human osteosarcoma cells. Int. J. Clin. Exp. Med. 6: 119–125
   PubMed Web of Science ®Google Scholar
• Belnoue, E., C. Tougne, A. F. Rochat, et al. 2012. Homing and adhesion patterns determine the cellular composition of the bone marrow plasma cell niche. J. Immunol. 188: 1283–1291
   PubMed Web of Science ®Google Scholar
• Minges Wols, H. A., G. H. Underhill, G. S. Kansas, and P. L. Witte. 2002. The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity. J. Immunol. 169: 4213–4221
   PubMed Web of Science ®Google Scholar
• Hjelmstrom, P., J. Fjell, T. Nakagawa, et al. 2000. Lymphoid tissue homing chemokines are expressed in chronic inflammation. Am. J. Pathol. 156: 1133–1138
   PubMed Web of Science ®Google Scholar
• Gatumu, M. K., K. Skarstein, A. Papandile, et al. 2009. Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjogren’s syndrome in salivary glands of non-obese diabetic mice. Arthritis Res. Ther. 11: R24
   PubMed Web of Science ®Google Scholar
• Manzo, A., S. Bugatti, R. Caporali, et al. 2007. CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis. Am. J. Pathol. 171: 1549–1562
   PubMed Web of Science ®Google Scholar
• Manzo, A., S. Paoletti, M. Carulli, et al. 2005. Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis. Eur. J. Immunol. 35: 1347–1359
   PubMed Web of Science ®Google Scholar
• Aqrawi, L. A., K. A. Brokstad, K. Jakobsen, et al. 2012. Low number of memory B cells in the salivary glands of patients with primary Sjogren’s syndrome. Autoimmunity. 45: 547–555
   PubMed Web of Science ®Google Scholar
• Sanderson, R. D., P. Lalor, and M. Bernfield. 1989. B lymphocytes express and lose syndecan at specific stages of differentiation. Cell. Regul. 1: 27–35
   PubMedGoogle Scholar
• Iwata, Y., Matsushita, T., Horikawa, M., et al. 2011. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 117: 530–541
   PubMed Web of Science ®Google Scholar
• Xiao, Y., Hendriks, J., Langerak, P., et al. 2004. CD27 is acquired by primed B cells at the centroblast stage and promotes germinal center formation. J. Immunol. 172: 7432–7441
   PubMed Web of Science ®Google Scholar
• Manz, R. A., A. Thiel, and A. Radbruch. 1997. Lifetime of plasma cells in the bone marrow. Nature. 388: 133–134
   PubMed Web of Science ®Google Scholar
• Tiburzy, B., M. Szyska, H. Iwata, et al. 2013. Persistent autoantibody-production by intermediates between short-and long-lived plasma cells in inflamed lymph nodes of experimental epidermolysis bullosa acquisita. PLoS One 8: e83631
   PubMed Web of Science ®Google Scholar